Deal Library / Pharma BD Deal Intelligence

Novo Nordisk — Pharma Deals

The Pharma Closeout tracks 13 deals, $550M in disclosed deal value for Novo Nordisk.

All 13 deals

• Novo Nordisk / Variant Bio — 2025
• Novo Nordisk / Replicate Bioscience — 2025 · $550M
• Novo Nordisk / IMMvention Therapeutix, Inc. — 2025
• Novo Nordisk / Cardior Pharmaceuticals — 2024
• Novo Nordisk / Ascendis Pharma — 2024
• Novo Nordisk / Embark Biotech — 2023
• Novo Nordisk / Genevant Sciences — 2023
• Novo Nordisk / Life Edit Therapeutics — 2023
• Novo Nordisk / Dewpoint Therapeutics — 2023
• Novo Nordisk / Fauna Bio — 2020
• Novo Nordisk / Embark Biotech — 2018
• Novo Nordisk / Kallyope — 2018
• Novo Nordisk / reMYND — 2017

← Deal Library  ·  Interactive search  ·  How we score deals